Curated News: Medical Meetings

• share
• favorite_border

A new study offers a new option to patients with oligometastatic prostate cancer who want relief from hormone therapy without compromising the risk of their disease spreading. In the study, patients who received radiation in addition to intermittent hormone therapy lived longer without their disease progressing, and they were able to take longer breaks from the drug treatments. Results of the phase II trial (EXTEND; NCT03599765) will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

• share
• favorite_border

The Presidential Symposium at the ongoing American Neurological Association 147th Annual Meeting outlined major risks to neurological health from environmental exposures to pesticides, air pollution, synthetic materials, and more — now emerging as a major research area in neuroscience.

• share
• favorite_border

Reducing the level of noise in the operating room (OR) may positively affect a child’s behavior, including fewer temper tantrums and more willingness to eat, in the days following surgery and anesthesia, according to research being presented at the ANESTHESIOLOGY® 2022 annual meeting.

• share
• favorite_border

A three-week course of radiation therapy is as safe and effective as four to six weeks of treatment for patients with early-stage breast cancer who have a higher risk of having their tumors recur, results of a randomized phase III clinical trial show. Delivering fewer, but higher, doses of radiation following lumpectomy, while concurrently delivering a radiation boost to the surgical site, led to similar outcomes as a longer course of treatment.

• share
• favorite_border

The American Neurological Association (ANA), the professional organization representing the world’s leading academic neurologists and neuroscientists, has appointed Brenda Orffer, CAE, as its new Chief Executive Officer and Nadine Goldberg, PhD, MS, as Chief Program Officer.

• share
• favorite_border

The American Society of Anesthesiologists (ASA) today presented Kristin Schreiber, M.D., Ph.D., with its 2022 James E. Cottrell Presidential Scholar Award in recognition of her exemplary translational research on post-surgical pain.

• share
• favorite_border

The American Society of Anesthesiologists (ASA) today presented Vivianne Tawfik, M.D., Ph.D., with its 2022 James E. Cottrell Presidential Scholar Award in recognition of her extraordinary contributions to the fundamental understanding of pain mechanisms to treat patients with chronic and post-surgical pain.

• share
• favorite_border

The American Society of Anesthesiologists (ASA) today presented David O. Warner, M.D., with its 2022 Excellence in Research Award in recognition of his extensive research efforts to help improve patient care before, during and after surgery.

• share
• favorite_border

Adding radiation therapy to systemic therapy for patients with advanced liver cancer can extend overall survival and delay tumor progression without compromising patients’ quality of life, a randomized phase III clinical trial shows.

• share
• favorite_border

In the face of conflicting evidence over the risks and benefits of routine prostate cancer screenings, a large, longitudinal analysis found Veterans Health Administration (VA) medical centers with lower prostate screening rates had higher rates of metastatic prostate cancer cases in subsequent years than centers with higher screening rates.

• share
• favorite_border

The American Society of Anesthesiologists (ASA) today presented Steven H. Rose, M.D., with its 2022 Excellence in Education Award in recognition of his exemplary leadership in physician and graduate medical education.

• share
• favorite_border

An artificial intelligence (AI) model developed by researchers can predict the likelihood that a patient may have an unplanned hospitalization during their radiation treatments for cancer. The machine-learning model uses daily step counts as a proxy to monitor patients’ health as they go through cancer therapy, offering clinicians a real-time method to provide personalized care. Findings will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

• share
• favorite_border

Wearing special green eyeglasses for several hours a day reduces pain-related anxiety and may help decrease the need for opioids to manage severe pain in fibromyalgia patients and possibly others who experience chronic pain, according to a study being presented at the ANESTHESIOLOGY® 2022 annual meeting.

• share
• favorite_border

Adults who use cannabis have more pain after surgery than those who don’t use cannabis, according to a study presented at the ANESTHESIOLOGY® 2022 annual meeting.

• share
• favorite_border

Using a novel response-adapted ultra-low dose radiation therapy strategy, MD Anderson researchers observed a 90% complete response rate in patients with orbital indolent B-cell lymphoma. The results were presented today at the 2022 ASTRO Annual Meeting.

• share
• favorite_border

The featured lectures at the 2022 ACG Annual Scientific Meeting and Postgraduate Course showcase innovative and challenging issues in clinical gastroenterology.

• share
• favorite_border

Featured science includes innovative approaches for IBD, colorectal cancer screening, IBS, GERD and Barrett’s esophagus, and more

• share
• favorite_border

Treating high-risk, asymptomatic bone metastases with radiation may reduce painful complications and hospitalizations and possibly extend overall survival in people whose cancer has spread to multiple sites, a phase II clinical trial suggests. Results of the multicenter, randomized trial (NCT03523351) will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

• share
• favorite_border

Meeting with a medical physicist who can explain how radiation therapy is planned and delivered reduces patient anxiety and increases patient satisfaction throughout the treatment process, according to a new study published today in the International Journal of Radiation Oncology • Biology • Physics. Findings of the randomized, prospective phase III clinical trial also will be presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

• share
• favorite_border

FLASH radiation treatment – which delivers therapeutic doses of radiation in a fraction of a second – may hold promise as a potential treatment for tough-to-kill tumors, a first-in-human study in a small number of people with bone cancer suggests.